Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 112Terminated 36Unknown 20Active not recruiting 8Withdrawn 5Recruiting 3Not yet recruiting 3Approved for marketing 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Renal Cell 2Kidney Neoplasms 1

Interventions

Gemcitabine 13Radiotherapy 12Androgen Antagonists 12Specimen Handling 11Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 8toripalimab 7darolutamide 7Drug Therapy 7Radiosurgery 6Docetaxel 6Cystectomy 6enzalutamide 5apalutamide 5Mitomycin 5Cisplatin 5Axitinib 5Abiraterone Acetate 5disitamab vedotin 4cabozantinib 4abiraterone 4Pluvicto 4Cyclophosphamide 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3Sunitinib 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Sunitinib × Genitourinary × Clear all
NCT07165418 2025-09-10

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

Peking University Cancer Hospital & Institute

Phase 3 Not yet recruiting
116 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT06032728 2023-09-13

Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

First Affiliated Hospital, Sun Yat-Sen University

Phase NA Not yet recruiting
488 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02688491 2016-02-25

A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

First Affiliated Hospital, Sun Yat-Sen University

Phase NA Not yet recruiting
300 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡